Skip to content
The El Paso

Experimental mRNA vaccine cuts risk melanoma returns by 42%

Experimental mRNA vaccine cuts risk melanoma returns by 42%
Photo: KVIA ABC-7 · view original

By Meg Tirrell, CNN (CNN) — When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage clinical trial in melanoma, oncologists and the public alike were exhilarated. And that was before its makers had even disclosed just how well th...

Sources and story details